Search
Sonoma Pharmaceuticals Inc
SNOAAdd to Watchlist
1.290USD
-0.015-1.15%
Close 09-14 16:00（ET）
6.17MMarket Cap
LossP/E TTM
Sonoma Pharmaceuticals Inc (SNOA) Stock Price Target & Forecast
Target Price
14.800USD+1198.25%
SNOA Analyst Recommendation Trends
In the current month, SNOA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SNOA average Analyst price target in the last month is 14.800.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
SNOA Analyst Rating for Peer Comparison
Updated: Sep 14, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, SNOA EPS is projected to reach -0.098 in FY2027Q2, following reported EPS of -0.086 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
Forecast
-0.30
-0.20
-0.30
-0.10
Actual
-0.48
-0.33
-0.09
--
Surprise
-56.76%
-67.43%
+71.11%
--
FAQs
What is Sonoma Pharmaceuticals Inc's expected revenue for the next quarter?
Sonoma Pharmaceuticals Inc's expected revenue is 5.29M.
What is Sonoma Pharmaceuticals Inc's price target?
Analysts forecast that Sonoma Pharmaceuticals Inc's price target is USD 14.80, with the highest forecast at USD 14.80 and the lowest forecast at USD 14.80.
How have Sonoma Pharmaceuticals IncSNOA's recent earnings per share performed?
The market expectation was USD -0.09, while Sonoma Pharmaceuticals IncSNOA's earnings per share (EPS) for the previous quarter was USD -0.33. EPS for the next quarter is expected at USD -0.10.